← Browse by Condition
Medical Condition

pregnant women

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for pregnant women sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pregnant women Clinical Trials

How many clinical trials are currently recruiting for pregnant women?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for pregnant women, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pregnant women?
pregnant women research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pregnant women clinical trial?
Eligibility criteria for pregnant women trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Top Sponsors
University Hospital, Clermont-Ferrand 1 trial
Alexandria University 1 trial
Women's Hospital School Of Medicine Zhejiang University 1 trial
Saglik Bilimleri Universitesi 1 trial
Massachusetts General Hospital 1 trial

Recruiting Clinical Trials

NCT06575309
Recruiting

THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Enrollment
50 pts
Location
France
Sponsor
University Hospital, Clermont-...
View Trial →
NCT06775431 Phase 3
Recruiting

Comparing Prophylactic Intravenous Pethidine and Intrathecal Pethidine in Preventing Post Spinal Shivering in Caesarean Section

Enrollment
86 pts
Location
Egypt
Sponsor
Alexandria University
View Trial →
NCT05776082
Recruiting

Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Enrollment
5,000 pts
Location
China, Rwanda
Sponsor
Women's Hospital School Of Med...
View Trial →
NCT07585916
Recruiting

Prenatal Yoga Intervention in Pregnant Women

Enrollment
46 pts
Location
Turkey (Türkiye)
Sponsor
Saglik Bilimleri Universitesi
View Trial →
NCT01246765
Recruiting

National Pregnancy Registry for Psychiatric Medications

Enrollment
5,000 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT05446571 Phase 3
Recruiting

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir

Enrollment
46 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology